Eculizumab in paraxysmal nocturnal haemogloburinia and atypical haemolytic syndrome 10-year pharmacovigilance analysis

Socie, G, Caby-Tosi, M-P, Marantz, JL et al. (7 more authors) (2019) Eculizumab in paraxysmal nocturnal haemogloburinia and atypical haemolytic syndrome 10-year pharmacovigilance analysis. British Journal of Haematology, 185 (2). pp. 297-310. ISSN 0007-1048

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2019, The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Keywords: paroxysmal nocturnal haemoglobinuria, atypical haemolytic uraemic syndrome, eculizumab, pharmacovigilance, safety.
Dates:
  • Published: April 2019
  • Accepted: 14 December 2018
  • Published (online): 15 February 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 30 Apr 2019 14:36
Last Modified: 30 Apr 2019 14:42
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/bjh.15790

Share / Export

Statistics